Mastodon

Larypront (Tablets) Instructions for Use

Marketing Authorization Holder

Hexalo Trading, Limited (Cyprus)

Manufactured By

October Pharma, S.A.E. (Egypt)

ATC Code

R02AA20 (Other antiseptics)

Active Substances

Lysozyme (DCF adopted for use in France)

Dequalinium chloride (Rec.INN registered by WHO)

Dosage Form

Bottle OTC Icon Larypront Lozenges 10 mg+250 mcg: 20 pcs.

Dosage Form, Packaging, and Composition

Lozenges 1 lozenge
Lysozyme hydrochloride 10 mg
Dequalinium chloride 250 mcg

10 pcs. – blister packs (2) – cardboard packs.

Clinical-Pharmacological Group

Topical antiseptic for use in ENT practice and dentistry

Pharmacotherapeutic Group

Antiseptic

Pharmacological Action

Lysozyme is a natural enzyme (mucopolysaccharidase) that forms a complex with viruses and prevents their penetration into cells, exerting an antiviral effect. It has an antimicrobial effect against gram-positive and some gram-negative bacteria by destroying the cell wall of microorganisms. Furthermore, lysozyme exerts anti-inflammatory, hemostatic, and mucolytic effects by blocking histamine, inactivating heparin, and breaking down mucopolysaccharides.

Dequalinium chloride is an antiseptic effective against gram-positive and gram-negative microorganisms, as well as fungi. By having the ability to reduce surface tension, it ensures the penetration of the active substances into the more deeply located areas of the mucous membrane.

Indications

Infectious and inflammatory diseases of the oral mucosa, pharynx, and larynx (gingivitis, periodontitis, stomatitis (including candidiasis, thrush), pharyngitis, laryngitis, tonsillitis); prevention of acute respiratory viral infections (ARVI); sore throat and hoarseness; before and after surgical interventions in the oral cavity and pharynx (dental operations, jaw surgery, maxillary sinus surgery, tonsil surgery).

ICD codes

ICD-10 code Indication
B37.0 Candidal stomatitis
J02 Acute pharyngitis
J03 Acute tonsillitis
J04.0 Acute laryngitis
J06.9 Acute upper respiratory infection, unspecified
J31.2 Chronic pharyngitis
J35.0 Chronic tonsillitis
J37.0 Chronic laryngitis
K05 Gingivitis and periodontal diseases
K12 Stomatitis and related lesions
R07.0 Pain in throat
R49 Voice disturbances
Z29.8 Other specified prophylactic measures
Z51.4 Preparatory procedures for subsequent treatment or examination, not elsewhere classified
ICD-11 code Indication
1F23.0 Candidiasis of the lips or oral mucosa
CA02.Z Acute pharyngitis, unspecified
CA03.Z Acute tonsillitis, unspecified
CA05.0 Acute laryngitis
CA07.0 Acute upper respiratory tract infection of unspecified site
CA09.2 Chronic pharyngitis
CA0F.Y Other specified chronic diseases of the palatine tonsils and adenoids
CA0G Chronic laryngitis or laryngotracheitis
DA01.Z Diseases of the oral mucosa, unspecified
DA0B.Z Gingival diseases, unspecified
DA0C.Z Periodontal diseases, unspecified
DA0Z Diseases or disorders of the orofacial complex, unspecified
MA82.Z Voice disturbances, unspecified
MD36.0 Pain in throat
QB9A Preparatory procedures for subsequent treatment
QC05.Z Prophylactic measures, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Dissolve one lozenge slowly in the mouth every two to three hours.

Adhere to a maximum of eight lozenges per 24-hour period.

For prevention of infectious and inflammatory conditions, reduce the frequency to one lozenge three times daily.

Use before and after surgical procedures in the oral cavity and pharynx as directed by a physician.

Initiate treatment at the first signs of throat discomfort, soreness, or hoarseness.

Continue treatment for several days after symptoms have resolved to ensure complete eradication of pathogens.

Do not exceed the recommended daily dose.

If symptoms persist beyond five days of self-treatment, discontinue use and consult a physician.

Adverse Reactions

In some cases, allergic reactions are possible.

Contraindications

Hypersensitivity to the components of the combination.

Use in Pregnancy and Lactation

Use during pregnancy and lactation is possible if indicated.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS